Rawson T, Moore L, Lamorde M
Commun Med (Lond). 2025; 5(1):67.
PMID: 40050472
PMC: 11885620.
DOI: 10.1038/s43856-025-00758-1.
Kassym L, Kussainova A, Semenov D, Aimurziyeva A, Uzbekova S, Semenova Y
Sci Rep. 2025; 15(1):6309.
PMID: 39984711
PMC: 11845685.
DOI: 10.1038/s41598-025-91216-4.
Abejew A, Gedif Fenta T, Wubetu G
Biomed Res Int. 2025; 2025:7676973.
PMID: 39949375
PMC: 11824853.
DOI: 10.1155/bmri/7676973.
Hlinkova S, Moraucikova E, Strzelecka A, Mrazova M, Littva V
J Clin Med. 2025; 14(3).
PMID: 39941669
PMC: 11818295.
DOI: 10.3390/jcm14031000.
Zhang L, Hu F, Zhao Z, Li X, Zhong M, He J
Elife. 2024; 13.
PMID: 39589395
PMC: 11594527.
DOI: 10.7554/eLife.98266.
Multiple impacts of the COVID-19 pandemic and antimicrobial stewardship on antimicrobial resistance in nosocomial infections: an interrupted time series analysis.
Li W, Yang X, Liu C, Liu X, Shi L, Zeng Y
Front Public Health. 2024; 12:1419344.
PMID: 39086796
PMC: 11288819.
DOI: 10.3389/fpubh.2024.1419344.
Morpholine-modified Ru-based agents with multiple antibacterial mechanisms as metalloantibiotic candidates against infection.
Lin S, Song Y, Sun Y, Lin W, Yu G, Liao X
RSC Adv. 2024; 14(28):20130-20144.
PMID: 38915333
PMC: 11194541.
DOI: 10.1039/d4ra02667e.
Editorial: Small non-coding RNAs in Gram negative bacteria.
Subhadra B, Sarshar M
Front Cell Infect Microbiol. 2024; 14:1426124.
PMID: 38803571
PMC: 11128658.
DOI: 10.3389/fcimb.2024.1426124.
Changing patterns of bacterial profile and antimicrobial resistance in high-risk patients during the COVID-19 pandemic at a tertiary oncology hospital.
Abdel-Hamid R, El-Mahallawy H, Allam R, Zafer M, Elswify M
Arch Microbiol. 2024; 206(6):250.
PMID: 38722362
DOI: 10.1007/s00203-024-03965-x.
Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017-2023: opportunities and gaps.
Sabbatucci M, Ashiru-Oredope D, Barbier L, Bohin E, Bou-Antoun S, Brown C
Pharmacol Res. 2024; 204:107188.
PMID: 38705262
PMC: 11156590.
DOI: 10.1016/j.phrs.2024.107188.
Assessment of antibiotic prescribing pattern and cost for hospitalized patients: A study from Palestine.
Manassrah R, Al Ramahi R
PLoS One. 2024; 19(5):e0302808.
PMID: 38696487
PMC: 11065265.
DOI: 10.1371/journal.pone.0302808.
Device-Associated Infections in COVID-19 Patients: Frequency of Resistant Bacteria, Predictors and Mortality in Medellín, Colombia.
Ocampo D, Echeverri-Toro L, Jimenez J, Salazar L, Vargas C, Roncancio G
Microorganisms. 2024; 12(4).
PMID: 38674585
PMC: 11051839.
DOI: 10.3390/microorganisms12040640.
Small RNA-modulated anaerobic respiration allows bacteria to survive under antibiotic stress conditions.
Kim D, Bhat A, Kim S, Lee S, Ryu C
Front Cell Infect Microbiol. 2024; 14:1287557.
PMID: 38577619
PMC: 10993149.
DOI: 10.3389/fcimb.2024.1287557.
Skin secretions of Leptodactylidae (Anura) and their potential applications.
Carrillo J, Boaretto A, Santana D, Silva D
J Venom Anim Toxins Incl Trop Dis. 2024; 30:e20230042.
PMID: 38374940
PMC: 10876013.
DOI: 10.1590/1678-9199-JVATITD-2023-0042.
Antimicrobial consumption in an acute NHS Trust during the COVID-19 pandemic: intervention time series analysis.
Khan S, Bond S, Lee-Milner J, Conway B, Lattyak W, Aldeyab M
JAC Antimicrob Resist. 2024; 6(1):dlae013.
PMID: 38328263
PMC: 10848649.
DOI: 10.1093/jacamr/dlae013.
Update of antimicrobial resistance in level III and IV health institutions in Colombia between January 2018 and December 2021.
De la Cadena E, Pallares C, Garcia-Betancur J, Porras J, Villegas M
Biomedica. 2023; 43(4):457-473.
PMID: 38109138
PMC: 10826464.
DOI: 10.7705/biomedica.7065.
Antimicrobial resistance control activities at a tertiary hospital in a low-resource setting: an example of Queen Elizabeth Central Hospital in Malawi.
Kamalo P, Iroh Tam P, Noniwa T, Mpanga C, Mulambia C, Phiri E
Front Antibiot. 2023; 2.
PMID: 38077777
PMC: 7615358.
DOI: 10.3389/frabi.2023.1202256.
Drug-Resistant Tuberculosis and COVID-19: A Scoping Review on a New Threat to Antimicrobial Resistance.
Silva B, Almeida A, Sergio M, Gatto T, Carasek V, Yamamura M
Rev Bras Enferm. 2023; 76Suppl 1(Suppl 1):e20220803.
PMID: 38055430
PMC: 10695069.
DOI: 10.1590/0034-7167-2022-0803.
Point Prevalence Survey of Antimicrobial Use and Resistance during the COVID-19 Era among Hospitals in Saudi Arabia and the Implications.
Haseeb A, Almarzoky Abuhussain S, Alghamdi S, Bahshwan S, Mahrous A, Alzahrani Y
Antibiotics (Basel). 2023; 12(11).
PMID: 37998811
PMC: 10668720.
DOI: 10.3390/antibiotics12111609.
Skewed perception of personal behaviour as a contributor to antibiotic resistance and underestimation of the risks.
Smith E, Buchan S
PLoS One. 2023; 18(11):e0293186.
PMID: 37917754
PMC: 10621963.
DOI: 10.1371/journal.pone.0293186.
